This paper discusses the challenges and opportunities facing medical technology executives as they explore new horizons for their medical innovations. It has practical tips on approaching new emerging healthcare markets as well as some of the struggles that manufacturers face in their efforts to broaden their company's horizons.
Get full access to this article
View all access options for this article.
References
1.
OECD (2003) A Disease-based Comparison of Health Systems: What is Best and at What Cost?Organisation for Economic Cooperation and Development, Paris.
2.
Wall Street Journal (2004) ‘On the Gurney’, J. Lahart cites the National Health Statistics group of the Centers for Medicare & Medicaid Services as reporting US health expenditures at 15% of GDP', 6 July.
